Literature DB >> 11252854

Cognition and behavior in patients with Alzheimer's disease.

B R Ott1.   

Abstract

Clinically relevant differences in cognition and behavior exist between men and women with Alzheimer's disease. Underlying these differences are variations in the topographic brain changes caused by pathologic processes, as well as differences in hormonal brain physiology and genetic influences. Our understanding of how these gender differences affect the clinical expression of Alzheimer's disease is in its infancy. Research in this area will likely yield further insights into potential therapies directed toward symptomatic and preventive interventions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11252854

Source DB:  PubMed          Journal:  J Gend Specif Med        ISSN: 1523-7036


  4 in total

1.  Differences in memory development among C57BL/6NCrl, 129S2/SvPasCrl, and FVB/NCrl mice after delay and trace fear conditioning.

Authors:  Amelia March; David Borchelt; Todd Golde; Christopher Janus
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

2.  Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.

Authors:  Scott E Counts; Shaoli Che; Stephen D Ginsberg; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2011-03-17       Impact factor: 3.052

3.  Normal cognition in transgenic BRI2-Aβ mice.

Authors:  Jungsu Kim; Paramita Chakrabarty; Amanda Hanna; Amelia March; Dennis W Dickson; David R Borchelt; Todd Golde; Christopher Janus
Journal:  Mol Neurodegener       Date:  2013-05-12       Impact factor: 14.195

4.  Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study.

Authors:  Delia Colombo; Carlo Caltagirone; Alessandro Padovani; Sandro Sorbi; Gianfranco Spalletta; Lucia Simoni; Alessandra Ori; Emanuela Zagni
Journal:  J Womens Health (Larchmt)       Date:  2018-09-08       Impact factor: 2.681

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.